Market Overview:
The global glycobiology/glycomics market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for glycomics products in oncology, diagnostics, immunology, drug discovery and development applications. Additionally, the increasing focus on personalized medicine is also contributing to the growth of this market. However, factors such as high cost of instruments and lack of skilled professionals are restraining the growth of this market. On the basis of type, enzymes account for a major share in this market owing to their wide range of applications in glycomics research. Oncology is one key application area for enzymes due to their ability to specifically cleave cancer-related proteins from glycans attached thereto.
Product Definition:
Glycomics is the study of the structure and function of glycans, which are complex carbohydrates found in all forms of life. Glycobiology is the subset of glycomics that focuses on how these molecules interact with proteins and other biological molecules. The importance of glycomics lies in its ability to help researchers understand how glycans contribute to health and disease. For example, by understanding the role that glycans play in cell-to-cell communication, scientists may be able to develop new treatments for cancer or other diseases.
Eagents:
Eagents are specific types of antigens that are found in the body fluids such as urine, blood, sweat and saliva. These antigens can be detected by the immune system and when they encounter an individual with a weak immune system they cause an allergic reaction. The common symptoms caused due to eagents include rash, itching or swelling of the skin, asthma attack or hives along with diarrhea or vomiting.
Enzymes:
Enzymes are proteins that act as catalysts and help in the chemical reactions. They are used for various applications such as research, biotechnology, clinical diagnosis, food industry and also play a vital role in environmental protection. Enzymes can be classified on the basis of their source (bacterial, fungal or animal) and use (endogenous or exogenous). Endotoxins are a group of enzymes produced by plants to protect them from pathogens.
Application Insights:
Oncology was the leading revenue-generating segment in 2017. Glycomics finds wide applications in cancer research, from biomarker discovery to drug development. It also offers potential solutions for cancer management, such as personalized medicine through targeted therapy and immunotherapy. Moreover, glycomics plays a vital role in improving the overall survival of patients with various cancers by enabling effective treatment options through early diagnosis and tracking disease progression.
The diagnostics segment is expected to witness lucrative growth over the forecast period owing to increasing adoption of glycome-based diagnostic tests for infectious diseases and chronic conditions such as diabetes mellitus, hemophilia A & B, rheumatoid arthritis among others. The rising prevalence of these disorders has led researchers to focus on advanced diagnostic techniques that are faster, more accurate than ever before while simultaneously reducing costs that may be incurred during extensive testing procedures carried out by laboratories today using conventional technologies (such as western blotting).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to increasing focus of major players on R&D activities and presence of well-established healthcare infrastructure. In addition, rising prevalence of chronic diseases such as diabetes, cancer, and others are anticipated to drive regional growth over the forecast period.
Asia Pacific is estimated to be fastest growing region during the same period due to factors such as improving healthcare facilities & infrastructure; increase in awareness about early diagnosis; rise in disposable income; and demand for cost-effective therapeutics & vaccines among others. Moreover, ongoing research activities by prominent glycoscience researchers will further boost regional growth over next eight years (Glycoscience Research Foundation). Glycoscience research foundation based in Japan has been working on various projects related with glyco biology since its inception (2002).
Growth Factors:
- Increasing demand for novel therapeutics and diagnostics: The global glycobiology/glycomics market is expected to grow at a CAGR of over 9% from 2016 to 2024, owing to the increasing demand for novel therapeutics and diagnostics. This is mainly due to the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases.
- Growing investments in R&D: The key players in the glycobiology/glycomics market are investing heavily in R&D to develop new products and technologies. This is helping them expand their product portfolios and strengthen their positions in the market.
- Rising awareness about glycomics: There is a growing awareness about glycomics among researchers, healthcare professionals, patients, and consumers worldwide. This is aiding the growth of the glycobiology/glycomics market considerably.
Scope Of The Report
Report Attributes
Report Details
Report Title
Glycobiology/Glycomics Market Research Report
By Type
Eagents, Enzymes, Kits, Instruments
By Application
Oncology, Diagnostics, Immunology, Drug Discovery and Development, Others
By Companies
Thermo Fisher Scientific, Agilent Technologies, New England Biolabs, Waters Corp, Bruker Corp, Sigma-Aldrich Corp, Takara Bio, Prozyme, Danaher Corp, Shimadzu Corp, Thermo Fisher Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
165
Number of Tables & Figures
116
Customization Available
Yes, the report can be customized as per your need.
Global Glycobiology/Glycomics Market Report Segments:
The global Glycobiology/Glycomics market is segmented on the basis of:
Types
Eagents, Enzymes, Kits, Instruments
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Diagnostics, Immunology, Drug Discovery and Development, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- Agilent Technologies
- New England Biolabs
- Waters Corp
- Bruker Corp
- Sigma-Aldrich Corp
- Takara Bio
- Prozyme
- Danaher Corp
- Shimadzu Corp
- Thermo Fisher Scientific
Highlights of The Glycobiology/Glycomics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Eagents
- Enzymes
- Kits
- Instruments
- By Application:
- Oncology
- Diagnostics
- Immunology
- Drug Discovery and Development
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Glycobiology/Glycomics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Glycobiology is the study of glycans, which are complex carbohydrates. Glycomics is the study of glycoproteins and glycolipids.
Some of the major companies in the glycobiology/glycomics market are Thermo Fisher Scientific, Agilent Technologies, New England Biolabs, Waters Corp, Bruker Corp, Sigma-Aldrich Corp, Takara Bio, Prozyme, Danaher Corp, Shimadzu Corp, Thermo Fisher Scientific.
The glycobiology/glycomics market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Glycobiology/Glycomics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Glycobiology/Glycomics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Glycobiology/Glycomics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Glycobiology/Glycomics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Glycobiology/Glycomics Market Size & Forecast, 2020-2028
4.5.1 Glycobiology/Glycomics Market Size and Y-o-Y Growth
4.5.2 Glycobiology/Glycomics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Eagents
5.2.2 Enzymes
5.2.3 Kits
5.2.4 Instruments
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Oncology
6.2.2 Diagnostics
6.2.3 Immunology
6.2.4 Drug Discovery and Development
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Glycobiology/Glycomics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Glycobiology/Glycomics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Eagents
9.6.2 Enzymes
9.6.3 Kits
9.6.4 Instruments
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Oncology
9.10.2 Diagnostics
9.10.3 Immunology
9.10.4 Drug Discovery and Development
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Eagents
10.6.2 Enzymes
10.6.3 Kits
10.6.4 Instruments
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Oncology
10.10.2 Diagnostics
10.10.3 Immunology
10.10.4 Drug Discovery and Development
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Eagents
11.6.2 Enzymes
11.6.3 Kits
11.6.4 Instruments
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Oncology
11.10.2 Diagnostics
11.10.3 Immunology
11.10.4 Drug Discovery and Development
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Eagents
12.6.2 Enzymes
12.6.3 Kits
12.6.4 Instruments
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Oncology
12.10.2 Diagnostics
12.10.3 Immunology
12.10.4 Drug Discovery and Development
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Eagents
13.6.2 Enzymes
13.6.3 Kits
13.6.4 Instruments
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Oncology
13.10.2 Diagnostics
13.10.3 Immunology
13.10.4 Drug Discovery and Development
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Glycobiology/Glycomics Market: Competitive Dashboard
14.2 Global Glycobiology/Glycomics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific
14.3.2 Agilent Technologies
14.3.3 New England Biolabs
14.3.4 Waters Corp
14.3.5 Bruker Corp
14.3.6 Sigma-Aldrich Corp
14.3.7 Takara Bio
14.3.8 Prozyme
14.3.9 Danaher Corp
14.3.10 Shimadzu Corp
14.3.11 Thermo Fisher Scientific
